PRINCETON, N.J. (PRWEB)
December 18, 2019
Soterius and Celegence are pleased to announce that as a part of Soterius’ Series A financing round, Celegence Holdings LLC has made a significant strategic investment in Soterius, Inc., a provider of outsourced services, collaboration technologies, and data assets in the drug safety and medical affairs space. The investment and partnership create synergies for both Celegence and Soterius, allowing each to leverage the knowledge and experience of their respective teams in order to expand reach and accelerate growth. Celegence is a Celegence Holdings LLC company that provides regulatory affairs services and technology to the life sciences industry to enable efficient and intelligent compliance with complex global and local regulatory requirements.
“Soterius has an effective delivery team, excellent client relationships and has developed a unique technology assets portfolio, all of which delivers significant operational efficiencies and quality improvements in drug safety and medical affairs to its clients,” says Sonia Veluchamy, CEO of Celegence. “By combining Celegence’s local regulatory insight, strategy, and intelligence with Soterius’ capabilities we can leverage our deep industry knowledge and expertise to introduce technologies and offer services that increase efficiencies for regulatory, safety and medical affairs departments.”
“The investment and the business agreements come at a great time as Soterius expands its footprint in different parts of the world and makes significant investments in people and technologies,” says Suneet Walia, CEO of Soterius, “The partnership expands access to global talent, clients, and relationships for both our organizations. We are now a combined force of more than 150 people deployed across the United States, Europe, and Asia, and are poised to scale up further as we expand our client portfolio and offer more comprehensive services to our clients from additional locations around the world.”
About Celegence
Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence supports life sciences customers in the areas of regulatory intelligence, RIMS, publishing, labelling, medical writing, and compliance with new regulations for different product portfolios. Celegence’s depth of experience and extensive delivery capability allows regulatory affairs teams to operate more efficiently, reduce cost, and improve compliance. For more information, visit http://www.celegence.com or follow Celegence on LinkedIn and Twitter.
About Soterius
Soterius is a trusted name in the life sciences industry for providing integrated outsourced drug safety and pharmacovigilance, medical affairs, and medical writing services with a customer base spanning Top 10 pharmaceutical companies, biopharmaceutical companies, global cosmetics conglomerates and generic drug manufacturers. Soterius supports life sciences companies through their drug development, approval, and commercialization processes, helping them find and deploy an optimal mix of outsourced and in-house operations. In addition to providing outsourced services, Soterius has several technology solutions and data assets that improve productivity, collaboration and compliance. For more information, visit http://www.soterius.com or follow Soterius on LinkedIn and Twitter.
Share article on social media or email: